Catheter-related bloodstream infection by Lindnera fabianii in a neutropenic patient

References

1. Alsina A., Mason M., Uphoff R. A., Riggsby W. S., Becker J. M., Murphy D. 1988; Catheter-associated Candida utilis fungemia in a patient with acquired immunodeficiency syndrome: species verification with a molecular probe. J Clin Microbiol 26:621–624[PubMed]
   [Google Scholar]
2. Bhally H. S., Jain S., Shields C., Halsey N., Cristofalo E., Merz W. G. 2006; Infection in a neonate caused by Pichia fabianii: importance of molecular identification. Med Mycol 44:185–187 [View Article][PubMed]
   [Google Scholar]
3. Bougnoux M. E., Gueho E., Potocka A. C. 1993; Resolutive Candida utilis fungemia in a non-neutropenic patient. J Clin Microbiol 31:1644–1645[PubMed]
   [Google Scholar]
4. Chandra J., Zhou G., Ghannoum M. A. 2005; Fungal biofilms and antimycotics. Curr Drug Targets 6:887–894 [View Article][PubMed]
   [Google Scholar]
5. CLSI (2008a Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Standard, M44, 2nd edn. Wayne, PA: Clinical and Laboratory Standards Institute
6. CLSI (2008b Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard, M27-A3, 3rd edn. Wayne, PA: Clinical and Laboratory Standards Institute
7. Concia E., Azzini A. M., Conti M. 2009; Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients. Drugs 69:Suppl. 15–14 [View Article][PubMed]
   [Google Scholar]
8. Diekema D. J., Messer S. A., Boyken L. B., Hollis R. J., Kroeger J., Tendolkar S., Pfaller M. A. 2009; In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J Clin Microbiol 47:3170–3177 [View Article][PubMed]
   [Google Scholar]
9. Dooley D. P., Beckius M. L., McAllister C. K., Jeffery B. S. 1990; Prostatitis caused by Hansenula fabianii . J Infect Dis 161:1040–1041 [View Article][PubMed]
   [Google Scholar]
10. Eggimann P., Garbino J., Pittet D. 2003; Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 3:685–702 [View Article][PubMed]
    [Google Scholar]
11. Gabriel F., Noel T., Accoceberry I. 2012; Lindnera (Pichia) fabianii blood infection after mesenteric ischemia. Med Mycol 50:310–314[PubMed] [CrossRef]
    [Google Scholar]
12. Grenouillet F., Millon L., Chamouine A., Thiriez G., Schulze O., Leroy J. 2010; Pichia fabianii fungemia in a neonate. Pediatr Infect Dis J 29:191 [View Article][PubMed]
    [Google Scholar]
13. Hamal P., Ostransky J., Dendis M., Horváth R., Ruzicka F., Buchta V., Vejsova M., Sauer P., Hejnar P., Raclavsky V. 2008; A case of endocarditis caused by the yeast Pichia fabianii with biofilm production and developed in vitro resistance to azoles in the course of antifungal treatment. Med Mycol 46:601–605 [View Article][PubMed]
    [Google Scholar]
14. Hazen K. C., Theisz G. W., Howell S. A. 1999; Chronic urinary tract infection due to Candida utilis . J Clin Microbiol 37:824–827[PubMed]
    [Google Scholar]
15. Kurtzman C. P., Robnett C. J. 1997; Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 35:1216–1223[PubMed]
    [Google Scholar]
16. León C., Alvarez-Lerma F., Ruiz-Santana S., León M. A., Nolla J., Jordá R., Saavedra P., Palomar M. EPCAN Study Group 2009; Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis 28:233–242[PubMed] [CrossRef]
    [Google Scholar]
17. Leroy O., Gangneux J. P., Montravers P., Mira J. P., Gouin F., Sollet J. P., Carlet J., Reynes J., Rosenheim M. other authors 2009; Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 37:1612–1618 [View Article][PubMed]
    [Google Scholar]
18. Lukić-Grlić A., Mlinarić-Missoni E., Skarić I., Vazić-Babić V., Svetec I. K. 2011; Candida utilis candidaemia in neonatal patients. J Med Microbiol 60:838–841 [View Article][PubMed]
    [Google Scholar]
19. Mukherjee P. K., Chandra J. 2004; Candida biofilm resistance. Drug Resist Updat 7:301–309 [View Article][PubMed]
    [Google Scholar]
20. Shih M. H., Sheu M. M., Chen H. Y., Lin S. R. 1999; Fungal keratitis caused by Candida utilis – case report. Kaohsiung J Med Sci 15:171–174[PubMed]
    [Google Scholar]
21. Shin J. H., Kee S. J., Shin M. G., Kim S. H., Shin D. H., Lee S. K., Suh S. P., Ryang D. W. 2002; Biofilm production by isolates of Candida species recovered from non-neutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40:1244–1248 [View Article][PubMed]
    [Google Scholar]
22. Valenza G., Valenza R., Brederlau J., Frosch M., Kurzai O. 2006; Identification of Candida fabianii as a cause of lethal septicaemia. Mycoses 49:331–334 [View Article][PubMed]
    [Google Scholar]
23. White T. J., Bruns T., Lee S., Taylor J. W. 1990 Amplification and Direct Sequencing of Fungal Ribosomal RNA Genes for Phylogenetics New York: Academic Press, Inc;
    [Google Scholar]